The efficacy of ultrasound-guided type-I and type-II pectoral nerve blocks for postoperative analgesia after breast augmentation: A prospective, randomised study

dc.contributor.authorKaraca, Omer
dc.contributor.authorPinar, Huseyin U.
dc.contributor.authorArpaci, Enver
dc.contributor.authorDogan, Rafi
dc.contributor.authorCok, Oya Y.
dc.contributor.authorAhiskalioglu, Ali
dc.contributor.orcID0000-0002-8467-8171en_US
dc.contributor.orcID0000-0003-0473-6763en_US
dc.contributor.orcID0000-0003-1933-2075en_US
dc.contributor.pubmedID29627431en_US
dc.contributor.researcherIDB-7473-2016en_US
dc.contributor.researcherIDQ-2420-2015en_US
dc.contributor.researcherIDAAU-6923-2020en_US
dc.date.accessioned2021-03-03T07:25:53Z
dc.date.available2021-03-03T07:25:53Z
dc.date.issued2019
dc.description.abstractPurpose: The present study was planned to evaluate the efficacy and safety of ultrasound-guided Pecs I and II blocks for postoperative analgesia after sub-pectoral breast augmentation. Methods: Fifty-four adult female patients undergoing breast augmentation were randomly divided into two groups: the control group (Group C, n = 27) who were not subjected to block treatment and Pecs group (Group P, n = 27) who received Pecs I (bupivacain 0.25%, 10 mL) and Pecs II (bupivacain 0.25%, 20 mL) block. Patient-controlled fentanyl analgesia was used for postoperative pain relief in both groups, and the patients were observed for the presence of any block-related complications. Results: The 24-h fentanyl consumption was smaller in Group P [mean +/- SD, 378.7 +/- 54.0 mu g and 115.7 +/- 98.1 mu g, respectively; P < 0.001]. VAS scores in Group P were significantly lower at the time of admission to the post-anaesthetic care unit and at 1, 2, 4, 8, 12, and 24 h (P < 0.001). The rates of nausea and vomiting were higher in Group C than in Group P (9 vs 2, P = 0.018). Hospital stay duration was shorter in Group P than in Group C (24.4 +/- 1.2 h vs 27.0 +/- 3.1 h, P < 0.001). No block-related complications were recorded. Conclusions: Combine used of Pecs I and II blocks provide superior postoperative analgesia in patients undergoing breast augmentation and shortens hospital stay. (C) 2018 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.en_US
dc.identifier.endpage52en_US
dc.identifier.issn2352-5568en_US
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85045853711en_US
dc.identifier.startpage47en_US
dc.identifier.urihttp://hdl.handle.net/11727/5473
dc.identifier.volume38en_US
dc.identifier.wos000455087000011en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.accpm.2018.03.009en_US
dc.relation.journalANAESTHESIA CRITICAL CARE & PAIN MEDICINEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnalgesia techniqueen_US
dc.subjectBreast augmentationen_US
dc.subjectPectoral nerves blocksen_US
dc.subjectPostoperative painen_US
dc.titleThe efficacy of ultrasound-guided type-I and type-II pectoral nerve blocks for postoperative analgesia after breast augmentation: A prospective, randomised studyen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: